227 related articles for article (PubMed ID: 18158559)
21. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation.
Kang GH; Lee HJ; Hwang KS; Lee S; Kim JH; Kim JS
Am J Pathol; 2003 Oct; 163(4):1551-6. PubMed ID: 14507661
[TBL] [Abstract][Full Text] [Related]
22. Promoter methylation of RNF180 is associated with H.pylori infection and serves as a marker for gastric cancer and atrophic gastritis.
Han F; Sun LP; Liu S; Xu Q; Liang QY; Zhang Z; Cao HC; Yu J; Fan DM; Nie YZ; Wu KC; Yuan Y
Oncotarget; 2016 Apr; 7(17):24800-9. PubMed ID: 27050149
[TBL] [Abstract][Full Text] [Related]
23. CpG methylation and reduced expression of O6-methylguanine DNA methyltransferase is associated with Helicobacter pylori infection.
Sepulveda AR; Yao Y; Yan W; Park DI; Kim JJ; Gooding W; Abudayyeh S; Graham DY
Gastroenterology; 2010 May; 138(5):1836-44. PubMed ID: 20044995
[TBL] [Abstract][Full Text] [Related]
24. Prediction of the risk for gastric cancer using candidate methylation markers in the non-neoplastic gastric mucosae.
Shin CM; Kim N; Park JH; Kang GH; Kim JS; Jung HC; Song IS
J Pathol; 2012 Mar; 226(4):654-65. PubMed ID: 22252584
[TBL] [Abstract][Full Text] [Related]
25. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
26. LINE-1 hypomethylation is associated with increased CpG island methylation in Helicobacter pylori-related enlarged-fold gastritis.
Yamamoto E; Toyota M; Suzuki H; Kondo Y; Sanomura T; Murayama Y; Ohe-Toyota M; Maruyama R; Nojima M; Ashida M; Fujii K; Sasaki Y; Hayashi N; Mori M; Imai K; Tokino T; Shinomura Y
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2555-64. PubMed ID: 18842996
[TBL] [Abstract][Full Text] [Related]
27. Demonstration of potential link between Helicobacter pylori related promoter CpG island methylation and telomere shortening in human gastric mucosa.
Tahara T; Shibata T; Okubo M; Kawamura T; Horiguchi N; Ishizuka T; Nakano N; Nagasaka M; Nakagawa Y; Ohmiya N
Oncotarget; 2016 Jul; 7(28):43989-43996. PubMed ID: 27259265
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic silencing of miR-137 is a frequent event in gastric carcinogenesis.
Steponaitiene R; Kupcinskas J; Langner C; Balaguer F; Venclauskas L; Pauzas H; Tamelis A; Skieceviciene J; Kupcinskas L; Malfertheiner P; Link A
Mol Carcinog; 2016 Apr; 55(4):376-86. PubMed ID: 25663388
[TBL] [Abstract][Full Text] [Related]
29. Increased number of methylated CpG islands correlates with Helicobacter pylori infection, histological and serological severity of chronic gastritis.
Tahara T; Arisawa T; Shibata T; Nakamura M; Yoshioka D; Okubo M; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Takahama K; Watanabe M; Yamashita H; Hirata I
Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):613-9. PubMed ID: 19307977
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach.
Loh M; Liem N; Vaithilingam A; Lim PL; Sapari NS; Elahi E; Mok ZY; Cheng CL; Yan B; Pang B; Salto-Tellez M; Yong WP; Iacopetta B; Soong R
BMC Gastroenterol; 2014 Mar; 14():55. PubMed ID: 24674026
[TBL] [Abstract][Full Text] [Related]
31. Effect of DNMT3A polymorphisms on CpG island hypermethylation in gastric mucosa.
Takano H; Shibata T; Nakamura M; Sakurai N; Hayashi T; Ota M; Nomura-Horita T; Hayashi R; Shimasaki T; Otsuka T; Tahara T; Arisawa T
BMC Med Genet; 2020 Oct; 21(1):205. PubMed ID: 33066747
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation as a molecular biomarker in gastric cancer.
Tahara T; Arisawa T
Epigenomics; 2015; 7(3):475-86. PubMed ID: 26077432
[TBL] [Abstract][Full Text] [Related]
33. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
[TBL] [Abstract][Full Text] [Related]
34. Lower LINE-1 methylation is associated with promoter hypermethylation and distinct molecular features in gastric cancer.
Tahara S; Tahara T; Horiguchi N; Okubo M; Terada T; Yoshida D; Funasaka K; Nakagawa Y; Shibata T; Tsukamoto T; Ohmiya N
Epigenomics; 2019 Nov; 11(15):1651-1659. PubMed ID: 31701771
[No Abstract] [Full Text] [Related]
35. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers.
Etoh T; Kanai Y; Ushijima S; Nakagawa T; Nakanishi Y; Sasako M; Kitano S; Hirohashi S
Am J Pathol; 2004 Feb; 164(2):689-99. PubMed ID: 14742272
[TBL] [Abstract][Full Text] [Related]
36. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
[TBL] [Abstract][Full Text] [Related]
37. Role of Helicobacter pylori infection in aberrant DNA methylation along multistep gastric carcinogenesis.
Shin CM; Kim N; Jung Y; Park JH; Kang GH; Kim JS; Jung HC; Song IS
Cancer Sci; 2010 Jun; 101(6):1337-46. PubMed ID: 20345486
[TBL] [Abstract][Full Text] [Related]
38. Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas.
Kim BH; Cho NY; Choi M; Lee S; Jang JJ; Kang GH
Arch Pathol Lab Med; 2007 Jun; 131(6):923-30. PubMed ID: 17550320
[TBL] [Abstract][Full Text] [Related]
39. Distinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas.
Kaneko Y; Sakurai S; Hironaka M; Sato S; Oguni S; Sakuma Y; Sato K; Sugano K; Saito K
Gut; 2003 May; 52(5):641-6. PubMed ID: 12692046
[TBL] [Abstract][Full Text] [Related]
40. Relationship between LINE-1 hypomethylation and Helicobacter pylori infection in gastric mucosae.
Kosumi K; Baba Y; Ishimoto T; Harada K; Miyake K; Izumi D; Tokunaga R; Murata A; Eto K; Sugihara H; Shigaki H; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Komohara Y; Takeya M; Baba H
Med Oncol; 2015 Apr; 32(4):117. PubMed ID: 25782871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
